Innovotech

Innovotech Share Buybacks

The Share Buybacks of Innovotech (IOT.V) as of Nov 20, 2026 is 527,963.00 CAD. In the previous year, Share Buybacks was 527,963.00 CAD — a change of 0.00% (lower).

Share Buybacks

527,963.00CAD

YoY

0.00%

Last updated:

Share Buybacks of Innovotech is 2017 527,963.00 CAD. Share Buybacks of Innovotech was 2016 527,963.00 CAD. It decreases by 0.00% lower compared to the previous year.

The Innovotech Share Buybacks history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Share Buybacks
Date
Share Buybacks
Jan 1, 2014
527,963.00 CAD
Jan 1, 2015
527,963.00 CAD
Jan 1, 2016
527,963.00 CAD
Jan 1, 2017
527,963.00 CAD
The Innovotech Share Buybacks history
YEARShare BuybacksYoY
527,963.00CAD0.00%
527,963.00CAD0.00%
527,963.00CAD0.00%
527,963.00CAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Innovotech Stock analysis

What does Innovotech do? Innovotech Inc. generates revenue through the sale of proprietary assay kits, including MBEC Assay Kits, Order Biofilm Assays, and Coated MBEC Assay Lids, which are used in microbial biofilm research. The company also provides contract research services such as Antimicrobial Contract Research, Antimicrobial and Anti-Biofilm Agents testing (MIC and MBEC), and Customized Antimicrobial Testing (BEST Assay Testing and Implanted Medical Device Testing). Its antimicrobial silver products, AgreGuard-1 Silver Antimicrobial for Crop Protection and InnovoSIL Antimicrobial Silver Products, are sold to customers in agricultural and medical sectors. The firm targets research institutions, agricultural producers, and medical device manufacturers seeking biofilm and antimicrobial testing solutions. Innovotech's intellectual property portfolio supports its contract research services, which include testing for antimicrobial agents and materials under standards like TM100, ISO 22196, and USP 51. The company’s Biofilm Publications and SEM Library serve as additional resources for clients engaged in biofilm research. Its product offerings are tailored to sectors requiring microbial biofilm analysis, such as crop protection and medical device development, with AgreGuard-1 and InnovoSIL products specifically addressing antimicrobial needs in agriculture and medical applications. The company monetizes its proprietary technology through direct sales of assay kits and antimicrobial silver products, while contract research services provide recurring revenue streams. Clients include research organizations conducting biofilm studies, agricultural businesses using AgreGuard-1 for crop protection, and medical device manufacturers utilizing InnovoSIL for antimicrobial properties. Innovotech’s focus on specialized testing methodologies and branded products ensures consistent demand from niche markets requiring precise biofilm and antimicrobial evaluation. Innovotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Innovotech stock

Share Buybacks of Innovotech is 527,963.00 CAD in 2017.

Share Buybacks of Innovotech changed from 527,963.00 CAD to 527,963.00 CAD, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Share Buybacks Innovotech since 2006 – with annual values, charts, and detailed analysis.

Share buybacks represent the cash spent repurchasing the company's own shares. Buybacks reduce shares outstanding and can increase EPS.

Share Buybacks's CAD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Share Buybacks's Innovotech historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Innovotech

All Key Metrics — Innovotech